The first monkeypox case in the United States was confirmed in Massachusetts; identification, measurement, and reduction of specific low-value services could help population health and reduce medical expenditures; President Joe Biden invokes the Defense Production Act to combat formula shortage.
New data show extreme heat waves were associated with higher all-cause mortality throughout the United States, with increased risks seen among men, the elderly, and non-Hispanic Black individuals.
Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, explains trends he expects to see in upcoming diabetes and weight loss studies.
The latest report from FAIR Health shows that the majority of people diagnosed post-COVID condition were never hospitalized.
American Oncology Network (AON) announced the appointment of Stephen "Fred" Divers, MD, a medical oncologist with Genesis Cancer and Blood Institute, as its new chief medical officer.
Latha Alaparthi, MD, gastroenterologist at Gastroenterology Center of Connecticut, talks about lessons she has learned from being a woman in a medical leadership position and what she hopes to teach others at the Women in GI Luncheon at Digestive Disease Week (DDW) 2022.
Real-world patients with psoriasis demonstrated significant improvement in difficult-to-treat scalp, nail, palmoplantar, and genital disease manifestations with the IL-23 inhibitor tildrakizumab.
Soumya Vishwanath, PharmD, senior manager of formulary management at Magellan Rx Management, explained what she wishes more people understood about digital therapeutics for behavioral health disorders.
The mobile app Color Me Healthy uses gamified elements to help children with cancer self-report their symptoms throughout treatment; all study participants reported symptoms at least once.
Locally advanced or metastatic basal cell carcinoma can be challenging to treat, but programmed death receptor 1 inhibition may hold potential as a tolerable, effective approach in patients of all ages.
Neil Goldfarb, president and chief executive officer of Greater Philadelphia Business Coalition on Health (GPBCH), provides an overview of the core discussion points and other aspects in-person attendees can look forward to at the 2022 GPBCH Annual Conference.
Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, explained the importance of taking multiple factors into consideration when making health care decisions.
Ryan Haumschild PharmD, MS, MBA, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute, spoke with AJMC® about health care resource utilization and clinical decision support in the care of patients with small cell lung cancer (SCLC).
New FDA legislation will reauthorize FDA user fee agreements for biosimilars, medical devices, and prescription and generic drugs; 7 cases of monkeypox have been confirmed in the United Kingdom, but its mode of transmission is still under investigation; according to a budget report, lowering the Medicare eligibility age to 60 would increase federal costs by $155 billion in a 5-year period.
Digestive Disease Week (DDW) 2022, held virtually and in San Diego, California, from May 21 to 24, will feature research and presentations exploring new ways to prevent and treat digestive diseases.
Across commercial insurance, Medicare, and Medicaid populations, oncology is the top category of spend, and the drug pipeline has increasing specific and complex therapies.
The researchers found that among subclasses, IgG1 expression was most prominent in samples from patients with multiple myeloma, and expression of IgG1 changed significantly before, throughout, and following treatment.
The pain, planning, emotional health, and fatigue quality of life domains were most impacted as a result of severe systemic lupus erythematosus (SLE) flares.
Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses the medicines discovery process and how real-world data can be used to evaluate patient and tumor response to treatment regimens.
Patients with cold agglutinin disease faced a 4.5-times greater risk of death during winter months, new data show.
A recent study found that limits on technology set by parents may play an important part in adolescent sleep.
Findings of the 52-week phase 3 LIBERTY AD PED-OLE trial showed dupilumab to have an adequate safety profile and incremental clinical benefit with continued use among pediatric patients with moderate to severe atopic dermatitis.
By predicting which individuals are most likely to require therapies for chronic kidney disease within the next year, health plans can better organize resource allocation to smooth or delay the transition for the patient, according to Rehan Waheed, MD of Quest Diagnostics.
A survey of patients and health care providers found both groups favor at-home administration of biologics when possible.
On this episode of Managed Care Cast, we speak with one of the authors of a paper published this month in Health Affairs about the utilization of substance use disorder treatment (SUD) services between 2010 and 2019, and why more needs to be done to get more individuals into treatment.
Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the potential of lab values can help health plans reach the Triple Aim of improving the patient experience, improving the health of populations, and reducing the per-member cost of health care.
A cross-sectional analysis found that protein biomarkers were associated with estimated glomerular filtration rate, which may capture early kidney impairment.
The report details totals paid to hospitals by private insurers and providers and compares the sums with a Medicare benchmark.
The findings are based off an analysis of 98,159 individuals.
While current data on medical cannabinoids in rheumatology is limited, findings suggest that adverse events (AEs) and drug interactions outweigh the benefits.